ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
2.060
-0.020 (-0.96%)
At close: Jan 23, 2026, 4:00 PM EST
2.090
+0.030 (1.46%)
After-hours: Jan 23, 2026, 7:55 PM EST
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $48.56 million as of January 23, 2026. Its market cap has increased by 547.40% in one year.
Market Cap
48.56M
Enterprise Value
50.77M
1-Year Change
547.40%
Ranking
Category
Stock Price
$2.06
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $48.56M, a decrease of -38.92%. That is a compound annual growth rate of -10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 50.10M | -3.28% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeurAxis | 51.77M |
| OS Therapies | 51.77M |
| iBio, Inc. | 50.60M |
| Aligos Therapeutics | 49.97M |
| Impact BioMedical | 49.36M |
| CEL-SCI | 49.02M |
| Instil Bio | 48.42M |
| Q32 Bio | 48.36M |